1,067,700 Shares in UiPath, Inc. $PATH Acquired by BW Gestao de Investimentos Ltda.

Key Points

• BW Gestao de Investimentos Ltda. acquired 1,067,700 shares of UiPath, Inc., valued at approximately $10.99 million, making it the fund's 29th largest position.
• Federated Hermes Inc. significantly increased its stake in UiPath by 479.3%, owning a total of 5,720,096 shares worth $58.92 million.
• Analysts have mixed opinions on UiPath, with the company's consensus rating being a "Hold" and a price target averaging $13.83.

BW Gestao de Investimentos Ltda. purchased a new position in UiPath, Inc. (NYSE:PATH - Free Report) in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 1,067,700 shares of the company's stock, valued at approximately $10,997,000. UiPath comprises about 0.3% of BW Gestao de Investimentos Ltda.'s portfolio, making the stock its 29th biggest position. BW Gestao de Investimentos Ltda. owned approximately 0.19% of UiPath as of its most recent SEC filing.

A number of other institutional investors also recently added to or reduced their stakes in PATH. Federated Hermes Inc. lifted its stake in UiPath by 479.3% in the first quarter. Federated Hermes Inc. now owns 5,720,096 shares of the company's stock worth $58,917,000 after acquiring an additional 4,732,712 shares during the last quarter. Candriam S.C.A. acquired a new position in UiPath in the first quarter valued at approximately $18,440,000. Jacobs Levy Equity Management Inc. boosted its holdings in UiPath by 35.6% in the fourth quarter. Jacobs Levy Equity Management Inc. now owns 5,459,071 shares of the company's stock valued at $69,385,000 after purchasing an additional 1,432,569 shares in the last quarter. Vanguard Group Inc. boosted its holdings in UiPath by 3.0% in the first quarter. Vanguard Group Inc. now owns 48,061,096 shares of the company's stock valued at $495,029,000 after purchasing an additional 1,396,972 shares in the last quarter. Finally, Armistice Capital LLC boosted its holdings in UiPath by 220.3% in the first quarter. Armistice Capital LLC now owns 1,799,689 shares of the company's stock valued at $18,537,000 after purchasing an additional 1,237,782 shares in the last quarter. Hedge funds and other institutional investors own 62.50% of the company's stock.

UiPath Price Performance

Shares of NYSE PATH opened at $10.92 on Wednesday. The stock has a fifty day moving average price of $11.85 and a 200 day moving average price of $11.90. UiPath, Inc. has a 1-year low of $9.38 and a 1-year high of $15.93. The company has a market cap of $5.84 billion, a PE ratio of -90.95, a P/E/G ratio of 14.57 and a beta of 1.02.

Insider Buying and Selling at UiPath

In related news, CEO Daniel Dines sold 9,988 shares of the stock in a transaction on Thursday, July 31st. The stock was sold at an average price of $12.00, for a total transaction of $119,856.00. Following the completion of the sale, the chief executive officer directly owned 4,598,388 shares of the company's stock, valued at $55,180,656. This trade represents a 0.22% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Insiders sold 831,310 shares of company stock worth $10,428,922 over the last three months. 23.19% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

A number of equities analysts recently issued reports on the company. Scotiabank upped their price target on UiPath from $12.00 to $13.00 and gave the company a "sector perform" rating in a report on Friday, May 30th. Evercore ISI upped their price target on UiPath from $11.00 to $15.00 and gave the company an "in-line" rating in a report on Friday, May 30th. Wells Fargo & Company reissued an "equal weight" rating on shares of UiPath in a report on Friday, May 30th. Zacks Research raised UiPath to a "hold" rating in a report on Friday, August 8th. Finally, BMO Capital Markets increased their price objective on UiPath from $11.50 to $15.50 and gave the company a "market perform" rating in a report on Friday, May 30th. Two analysts have rated the stock with a Buy rating, thirteen have issued a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat, UiPath presently has a consensus rating of "Hold" and a consensus price target of $13.83.

UiPath Company Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.

Want to see what other hedge funds are holding PATH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UiPath, Inc. (NYSE:PATH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.